ライフサイエンスコーパス: diaminobenzidine

1 ic cells were labeled with biocytin and 3,3'-diaminobenzidine.

2 ifferent substrates: CL, etoposide, and 3,3'-diaminobenzidine.

3 Immunoreactivity was visualized using diaminobenzidine.

4 ined for collagen type I and developed using diaminobenzidine.

5 led with Neurobiotin and visualized with 3,3'diaminobenzidine.

6 r PHA-L using the avidin biotin complex with diaminobenzidine.

7 yzed the internalized dye in the presence of diaminobenzidine.

8 Staining of brain sections with diaminobenzidine after perfusion with manganese buffer a

9 , and used to trigger the photoconversion of diaminobenzidine, allowing 4D optical recording on live

10 otein (IN-1), followed by visualization with diaminobenzidine and a peroxidase-conjugated secondary a

11 PCR, chromatin immunoprecipitation, and 3,3'-diaminobenzidine and aniline blue staining.

12 polymers were prepared from the neutral 3,3'-Diaminobenzidine and catalytic amounts of aqueous HCl.

13 ght and electron microscopic levels by using diaminobenzidine and gold-substituted silver-intensified

14 nctionally inactivated by cross-linking with diaminobenzidine and hydrogen peroxide.

15 ptor, p53, and androgen receptor staining by diaminobenzidine and MxIF methods yielded similar result

16 ynapses between PNMT-ir boutons labeled with diaminobenzidine and orexinergic neurons labeled with im

17 commonly used for phenoloxidases, e.g., 3,3-diaminobenzidine, and was close to that attainable for p

18 VAChT(+) terminals were visualized by using diaminobenzidine as a chromogen, whereas CAMK(+) or PV(+

19 with peroxidase-catalyzed polymerization of diaminobenzidine as a read-out.

20 pplied to 30 mum free-floating sections with diaminobenzidine as the chromogen.

21 cessed for glycine immunocytochemistry using diaminobenzidine as the chromogen.

22 he method is based on polymerization of 3,3'-diaminobenzidine by endocytosed horseradish peroxidase,

23 ssion discordance or heterogeneity using the diaminobenzidine chromogen and QIF was the main outcome

24 e catalyzed product was visualized with 3,3'-diaminobenzidine Chromogen Kit and lightly counterstaine

25 with red chromogen and Ki67 with brown 3,3'-diaminobenzidine chromogen.

26 and a 2- to 45-min staining period with 3,3-diaminobenzidine (DAB) and hydrogen peroxide (H2O2).

27 le panmelanoma cocktail (dPANMEL) using 3,3'-diaminobenzidine (DAB) and VR.

28 an antiserum raised against DOR or MOR using diaminobenzidine (DAB) as the chromogen.

29 and a previous study on AD brains utilized a diaminobenzidine (DAB) enhanced version of this stain.

30 acutely triggered the polymerization of 3,3'-diaminobenzidine (DAB) in the Golgi lumen.

31 , after which sections were reacted with 3,3-diaminobenzidine (DAB) in the presence of hydrogen perox

32 f H2O2 was detected in the root hairs by 3,3-diaminobenzidine (DAB) stain 72h after bacterial inocula

33 In the presence of diaminobenzidine (DAB), photoactivation of dye-filled ve

34 e culture was monitored with the use of 3,3'-diaminobenzidine (DAB).

35 ed with a chromogenic substrate (either 3.3'-diaminobenzidine [DAB] or SG [Vector Labs, Inc.]) which

36 hout the neuropil and were highly irregular, diaminobenzidine-dense profiles that had pleiomorphic mo

37 n, dot blotting, Perls' histochemistry, 3,3'-diaminobenzidine enhancement, and densitometry.

38 ric antrum were collected and processed with diaminobenzidine for permanent tracer labeling.

39 on in leaf cells visible by ferrocyanide and diaminobenzidine-H(2)O(2) staining.

40 ation of C5-DMB-ceramide, in the presence of diaminobenzidine, identified DMB-lipids in vesicles in t

41 on 40-microm free-floating sections using a diaminobenzidine labeling procedure.

42 ted secondary antibodies and developing with diaminobenzidine or by using fluorescent secondary antib

43 Cytochemical visualization of catalase using diaminobenzidine precipitation gives a vesicular stainin

44 facilitate the chromogenic oxidation of 3,3'-diaminobenzidine, producing an insoluble brown precipita

45 Iron uptake was evaluated with 3,3'-diaminobenzidine-Prussian blue staining, lysosomal stain

46 We utilized a diaminobenzidine reaction enhanced with nickel to compar

47 Using nickel and cobalt to enhance the diaminobenzidine reaction product, we observed large lay

48 neurons of the duodenum and jejunum using a diaminobenzidine reaction.

49 tin and visualized with an antibody enhanced diaminobenzidine reaction.

50 tric analysis of brain sections reacted with diaminobenzidine showed significantly greater extravascu

51 In a comparison of pathologist scoring of diaminobenzidine staining of serial sections and automat

52 cruitment of neutrophils identified by 3,3'- diaminobenzidine staining, and goblet cell degranulation

53 Immunofluorescence and 3,3' diaminobenzidine tetrahydrochloride (DAB) labeling verif

54 amine (BDA) with Vector slate grey and 3,3'-diaminobenzidine tetrahydrochloride as the chromagens.

55 Treatment of 3,3'-Diaminobenzidine tetrahydrochloride hydrate with 1,2,4,5

56 lved in PLC signal transduction, we used 3,3'diaminobenzidine tetrahydrochloride immunoelectron micro

57 n was detected with Perl's staining and 3,3'-diaminobenzidine-tetrahydrochloride enhanced Turnbull bl

58 ased on horseradish peroxidase conversion of diaminobenzidine to a colored insoluble product.

59 ent endocytotic marker FM 1-43 by using 3,3'-diaminobenzidine to convert the dye signal into an elect